RUBY
Dead / Abandoned — Abandoned — failure to respond (as of 21 Apr 2025)
What this means for you
This application is over — abandoned 03 Apr 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79399250
- Mark type
- Stylized text
- Filed
- 14 Mar 2024
- Abandoned
- 03 Apr 2025
Goods and services
- Class 001 — Chemicals: Proteins for use in science, industry or manufacture; enzymes; polymers; chemical and biochemical preparations and substances used in industry, agriculture or foodstuffs; chemical diagnostic reagents for industrial use; diagnostic reagents for scientific use; chemicals for analytical, diagnostic and immunological purposes and laboratory use; chemicals for use in the manufacture of pharmaceuticals; libraries and collections of the aforementioned chemicals; antibodies for scientific purposes, other than for medical or veterinary use; libraries and collections of antibodies; antibody formats; bispecific antibody formats, therapeutic antibodies; bispecific antibody formats for immuno-oncological applications; bispecific compounds.
- Class 005 — Pharmaceuticals: Proteins; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical use; enzymes for medical purposes; diagnostic reagents; antibodies and libraries of antibodies for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for immuno-oncological applications; immuno-oncology preparations for medical and pharmaceutical purposes.
- Class 042 — Scientific and technological services: Bio-technology and scientific research services relating to antibodies, proteins, enzymes, antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific compounds, immune-oncology antibody preparations and pharmaceuticals; research, production and development services relating to antibodies, proteins and enzymes; biological and bio-technology analysis services and laboratory services relating to antibodies, proteins, enzymes, antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific compounds, immune-oncology antibody preparations and pharmaceuticals; biochemical research and development in the field of antibodies, protein and enzyme; scientific laboratory services relating to antibodies, protein and enzyme; research, production and development services relating to antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds; research, development and production of immuno-oncology antibody preparations and pharmaceuticals; information, advisory and consultancy services relating to all of the aforesaid services.
Owner
Prosecution history
- 18 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 03 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 03 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 21 Apr 2025 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 21 Apr 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 19 Oct 2024 — REFUSAL PROCESSED BY IB
- 02 Oct 2024 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 02 Oct 2024 — REFUSAL PROCESSED BY MPU
- 27 Sept 2024 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 26 Sept 2024 — NON-FINAL ACTION WRITTEN
- 24 Sept 2024 — ASSIGNED TO EXAMINER
- 11 Jul 2024 — APPLICATION FILING RECEIPT MAILED
- 11 Jul 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Jul 2024 — SN ASSIGNED FOR SECT 66A APPL FROM IB